Researchers play down AI apocalypse fears, citing hurdles to creating a killer virus

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-16T12:54:20.858Z • Permanent link

Physicist John Wilbanks, a prominent biosecurity expert, has been making headlines for his latest research on the feasibility of creating a killer AI virus. According to Wilbanks, the prospect of an AI apocalypse is largely overstated due to significant hurdles in engineering such a virus. Wilbanks' research, published in a recent article in the journal Nature Biotechnology, highlights the difficulties in designing and testing viruses that can evade human control. The article specifically cites the challenges posed by the complexity of viral genomes and the need for rigorous testing and validation.

The research was conducted in collaboration with the National Institutes of Health (NIH) and the University of California, Los Angeles (UCLA). The team used advanced computational models to simulate the behavior of viral genomes and identify potential weaknesses. The study found that even with the most advanced technologies, it is unlikely that a killer AI virus could be created without significant risks to human safety. Wilbanks emphasizes that the focus should be on developing more robust and secure methods for designing and testing viral genomes, rather than speculating about the possibility of an AI apocalypse.

Meanwhile, cybersecurity expert Dr. Rachel Kim has been warning about the dangers of AI-powered cyberattacks for years. Kim's research has focused on the vulnerabilities of critical infrastructure, including power grids and financial systems. Her work has been influential in shaping policy and regulatory approaches to addressing these threats. According to Kim, the recent research by Wilbanks and his team provides a much-needed dose of realism about the challenges of creating a killer AI virus. "We've been focusing on the wrong problem," Kim says. "The real challenge is not creating a killer virus, but preventing it from being used in the first place.

The implications of Wilbanks' research are significant for companies and research communities in the field of biosecurity. Organizations such as the National Institute of Allergy and Infectious Diseases (NIAID) and the World Health Organization (WHO) will need to reassess their approaches to designing and testing viral genomes. The development of more robust and secure methods for viral genome design and testing will require significant investment in research and development. Companies such as biotech firms and pharmaceutical companies will also need to adapt their approaches to ensure that their products are safe and effective.

The impact of Wilbanks' research will also be felt in the financial markets. The recent surge in volatility in the biotech sector has been attributed in part to concerns about the potential for AI-powered cyberattacks on critical infrastructure. Wilbanks' research provides a more nuanced understanding of the risks and challenges associated with these threats. As a result, investors and policymakers will need to reassess their approaches to addressing these risks. The development of more robust and secure methods for viral genome design and testing will require significant investment in research and development.

The debate about the feasibility of creating a killer AI virus is not new. In recent years, there has been a growing concern about the potential risks of AI-powered cyberattacks on critical infrastructure. This concern has been fueled in part by high-profile incidents such as the WannaCry ransomware attack in 2017. The attack, which affected hospitals and other critical infrastructure, highlighted the vulnerability of these systems to AI-powered cyberattacks. In response, policymakers and regulators have begun to develop new approaches to addressing these risks.